Xarelto (rivaroxaban)

pCPA File Number: 20785
Negotiation Status:
Concluded with an LOI
Indication(s):
Atrial fibrillation, stroke prevention
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
S0257
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: